Dezapelisib (INCB-040093; INCB040093) is a novel and potent inhibitor of phosphoinositide-3 kinases (PI3K) with anticancer activity. It inhibits PI3Kδ with IC50 of 31 nM, exhibits 74 to >900-fold selectivity for the other PI3K family members, and does not inhibit a panel of 57 additional kinases. Dezapelisib demonstrates high efficacy in patients with Hodgkin's lymphoma in clinical studies.

纯度：≥98%

CAS：1262440-25-4